News
The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.
The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...
The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...
2d
Pharmaceutical Technology on MSNFDA approves GSK’s prefilled syringe presentation of ShingrixThe US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...
SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for ...
Our PICO syringes help you deliver a blood sample with high analytical quality. This is because they contain Radiometer’s uniquely formulated dry, electrolyte-balanced heparin. It prevents clots ...
5d
Packaging Gateway on MSNThe basics of parenteral packaging for injectable drugsParenteral packaging is the specialised packaging used to store and protect medicines that are administered by injection.
CSL has FDA approval for its new drug to prevent hereditary angioedema (HAE) attacks, Andembry, offering a new, first-in-class option for patients with the rare genetic disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results